Bionyra Pharma Emerges from Stealth with $165M Series A to Redefine Immunology
In a significant move that underscores the continued investor appetite for high-precision immunology, Bionyra Pharma has officially emerged from stealth...
pharma
In a significant move that underscores the continued investor appetite for high-precision immunology, Bionyra Pharma has officially emerged from stealth...
